Hamel Associates’s AbbVie ABBV Stock Holding History

Hamel Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.82M	Sell	20,555 -150	-0.7%	-$27.8K	1.29%	31
2025 Q1	$4.34M	Buy	20,705 +150	+0.7%	+$31.4K	1.47%	29
2024 Q4	$3.65M	Hold	20,555	–	–	1.18%	31
2024 Q3	$4.06M	Hold	20,555	–	–	1.24%	32
2024 Q2	$3.53M	Sell	20,555 -3,666	-15%	-$629K	1.11%	33
2024 Q1	$4.41M	Sell	24,221 -2,975	-11%	-$542K	1.41%	29
2023 Q4	$4.21M	Sell	27,196 -225	-0.8%	-$34.9K	1.49%	26
2023 Q3	$4.09M	Hold	27,421	–	–	1.49%	28
2023 Q2	$3.69M	Sell	27,421 -225	-0.8%	-$30.3K	1.29%	32
2023 Q1	$4.41M	Sell	27,646 -65	-0.2%	-$10.4K	1.53%	27
2022 Q4	$4.48M	Sell	27,711 -250	-0.9%	-$40.4K	1.56%	26
2022 Q3	$3.75M	Sell	27,961 -300	-1%	-$40.3K	1.49%	25
2022 Q2	$4.33M	Sell	28,261 -250	-0.9%	-$38.3K	1.71%	21
2022 Q1	$4.62M	Sell	28,511 -4	-0%	-$648	1.64%	23
2021 Q4	$3.86M	Buy	28,515 +50	+0.2%	+$6.77K	1.38%	27
2021 Q3	$3.07M	Buy	28,465 +1,310	+5%	+$141K	1.2%	34
2021 Q2	$3.06M	Buy	27,155 +13,250	+95%	+$1.49M	1.17%	37
2021 Q1	$1.51M	Buy	+13,905	New	+$1.51M	0.58%	48
2018 Q1	–	Sell	-2,150	Closed	-$208K	–	92
2017 Q4	$208K	Buy	+2,150	New	+$208K	0.1%	83
2017 Q1	–	Sell	-10,075	Closed	-$631K	–	79
2016 Q4	$631K	Sell	10,075 -1,475	-13%	-$92.4K	0.33%	57
2016 Q3	$728K	Sell	11,550 -10,000	-46%	-$630K	0.39%	54
2016 Q2	$1.33M	Sell	21,550 -1,200	-5%	-$74.3K	0.69%	46
2016 Q1	$1.3M	Sell	22,750 -250	-1%	-$14.3K	0.69%	46
2015 Q4	$1.36M	Sell	23,000 -450	-2%	-$26.6K	0.87%	38
2015 Q3	$1.28M	Hold	23,450	–	–	0.91%	37
2015 Q2	$1.58M	Buy	23,450 +1,025	+5%	+$68.9K	1.04%	36
2015 Q1	$1.31M	Buy	22,425 +1,300	+6%	+$76.1K	0.87%	43
2014 Q4	$1.38M	Hold	21,125	–	–	0.9%	43
2014 Q3	$1.22M	Sell	21,125 -2,225	-10%	-$128K	0.81%	45
2014 Q2	$1.32M	Sell	23,350 -100	-0.4%	-$5.66K	0.87%	39
2014 Q1	$1.21M	Sell	23,450 -5,225	-18%	-$268K	0.83%	45
2013 Q4	$1.51M	Buy	+28,675	New	+$1.51M	1.06%	35